Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Bussel

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Seminars in Hematology|July 4, 2006
Treatment of immune thrombocytopenic purpura in adultsJames Bussel
Seminars in Hematology|July 4, 2006
Review of therapies for immune thrombocytopenic purpuraJames Bussel, Michael Tarantino
British Journal of Haematology|November 8, 2023
Improving the chances of response to splenectomy in immune thrombocytopeniaSylvain Audia, James Bussel
Leukemia & Lymphoma|October 20, 2018
TPO-mimetics for chemotherapy-induced thrombocytopenia: timing mattersJerry Soff, James Bussel
British Journal of Haematology|August 2, 2021
Familial thrombocythaemia - a distinct entity from essential thrombocythaemiaJames Bussel, Nicole Kucine
Current Opinion in Hematology|October 16, 2007
New therapies for immune thrombocytopenic purpuraBiree Andemariam, James Bussel
Clinical Hematology International|October 1, 2021
Immune Thrombocytopenia: Are We Stuck in the Mud or Is There Light at the End of the Tunnel?James Bussel, Oriana Miltiadous
British Journal of Haematology|April 29, 2006
The pathogenesis of immune thrombocytopaenic purpuraNichola Cooper, James Bussel
British Journal of Haematology|August 4, 2004
Immune thrombocytopenic purpura: investigation of the role of cytomegalovirus infectionAdam S Levy, James Bussel
Haematologica|May 26, 2019
Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?Elisa Lucchini, Francesco Zaja, James Bussel
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Seminars in Hematology|July 4, 2006
Treatment of immune thrombocytopenic purpura in adultsJames Bussel
Seminars in Hematology|July 4, 2006
Review of therapies for immune thrombocytopenic purpuraJames Bussel, Michael Tarantino
British Journal of Haematology|November 8, 2023
Improving the chances of response to splenectomy in immune thrombocytopeniaSylvain Audia, James Bussel
Leukemia & Lymphoma|October 20, 2018
TPO-mimetics for chemotherapy-induced thrombocytopenia: timing mattersJerry Soff, James Bussel
British Journal of Haematology|August 2, 2021
Familial thrombocythaemia - a distinct entity from essential thrombocythaemiaJames Bussel, Nicole Kucine
Current Opinion in Hematology|October 16, 2007
New therapies for immune thrombocytopenic purpuraBiree Andemariam, James Bussel
Clinical Hematology International|October 1, 2021
Immune Thrombocytopenia: Are We Stuck in the Mud or Is There Light at the End of the Tunnel?James Bussel, Oriana Miltiadous
British Journal of Haematology|April 29, 2006
The pathogenesis of immune thrombocytopaenic purpuraNichola Cooper, James Bussel
British Journal of Haematology|August 4, 2004
Immune thrombocytopenic purpura: investigation of the role of cytomegalovirus infectionAdam S Levy, James Bussel
Haematologica|May 26, 2019
Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?Elisa Lucchini, Francesco Zaja, James Bussel
Pageof 6